Royal Bank of Canada’s Pacer BioThreat Strategy ETF VIRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,729
| Closed | -$109K | – | 6805 |
|
|
2024
Q3 | $109K | Buy |
2,729
+141
| +5% | +$5.63K | ﹤0.01% | 4841 |
|
|
2024
Q2 | $94K | Buy |
2,588
+1,619
| +167% | +$58.8K | ﹤0.01% | 4923 |
|
|
2024
Q1 | $35K | Buy |
+969
| New | +$35K | ﹤0.01% | 5247 |
|
|
2023
Q4 | – | Sell |
-22,059
| Closed | -$658K | – | 7071 |
|
|
2023
Q3 | $658K | Buy |
22,059
+4,312
| +24% | +$129K | ﹤0.01% | 3351 |
|
|
2023
Q2 | $554K | Buy |
17,747
+8,500
| +92% | +$265K | ﹤0.01% | 3482 |
|
|
2023
Q1 | $271K | Buy |
9,247
+6,646
| +256% | +$195K | ﹤0.01% | 4013 |
|
|
2022
Q4 | $73K | Sell |
2,601
-11,119
| -81% | -$312K | ﹤0.01% | 5208 |
|
|
2022
Q3 | $346K | Sell |
13,720
-13,030
| -49% | -$329K | ﹤0.01% | 3861 |
|
|
2022
Q2 | $712K | Buy |
26,750
+18,577
| +227% | +$494K | ﹤0.01% | 3373 |
|
|
2022
Q1 | $253K | Sell |
8,173
-14,173
| -63% | -$439K | ﹤0.01% | 4408 |
|
|
2021
Q4 | $778K | Buy |
22,346
+20,202
| +942% | +$703K | ﹤0.01% | 3588 |
|
|
2021
Q3 | $70K | Sell |
2,144
-3,385
| -61% | -$111K | ﹤0.01% | 5445 |
|
|
2021
Q2 | $176K | Sell |
5,529
-41,281
| -88% | -$1.31M | ﹤0.01% | 4713 |
|
|
2021
Q1 | $1.36M | Buy |
46,810
+18,276
| +64% | +$531K | ﹤0.01% | 2927 |
|
|
2020
Q4 | $797K | Sell |
28,534
-2,688
| -9% | -$75.1K | ﹤0.01% | 3231 |
|
|
2020
Q3 | $869K | Buy |
31,222
+30,544
| +4,505% | +$850K | ﹤0.01% | 2965 |
|
|
2020
Q2 | $17K | Buy |
+678
| New | +$17K | ﹤0.01% | 5187 |
|